S&P 500 at Risk as Tightening Restrictions Douse Vaccine Optimism

The S&P 500 has struggled to establish a firm foothold above the landmark 3600 level despite a flurry of positive coronavirus vaccine headlines, as surging infection numbers force regional authorities to tighten restrictions in several US states.